Natural Microbial Defences & Immunity
Humans are associated with microorganisms, as they even colonize in the body like S.aureus in the upper respiratory tract but it may not be harmful to the host and micro inflammation is a body’s defensive response towards an invading microorganism as an effort for self-protection to eradicate harmful stimuli. There are innate immune systems (primary defense mechanism) and adaptive immune system (secondary defence mechanism). Immunogenetics is a subspeciality of medicine that studies the relationship between genetics and immunology. Immunogenetics helps in understanding the pathogenesis of several autoimmune and infectious diseases and bacterial infections under clinical bacteriology also. The effect of pathogen on host not only depends upon the virulence factor but also depend upon the host’s genetic background. Some species shows innate susceptibility to pathogen not with host like syphilis, gonorrhoea, measles and poliomyelitis act on humans alone. The anatomical defense includes penetration of bacteria through the cut, puncture or scrap on the skin. There are some others like phagocytosis, inflammation through which bacteria can enter the host. Cell mediated immunity cytotoxic T lymphocytes, and the release of various cytokines in response to an antigen.CD4 cells. For a good and proper health conditions, there is a need to improve immune systems. In the total adult population of US only 3% are able to manage the stress (10%), energy (15%) and sleep (11%) and a compromised immune system simultaneously.
- Cellular & Molecular defects in human B cell development
- Immunologic basis of cow milk induced hypersensitivities
- Adaptive immune interaction in gut inflammation
- Immunobiology of peanut allergy and its treatment: A prototype
- Generation and characterization of intestinal CD8+ Regulatory T cell lines
- Meningococcal meningitis
- Respiratory pathogen inducing apoptosis
- Postoperative surgical site bacterial infections and drug susceptibility
- Contribution of pathogenic bacteria to GI symptoms in parasite-free patients
- Potential activity of hydroxychavicol against pathogenic bacteria
Related Conference of Natural Microbial Defences & Immunity
7th International Conference on Microbiology and Infectious Diseases
10th International Conference on Infectious Diseases: Control and Prevention
7th World Congress on Tuberculosis, Lung Infections, and Respiratory Care
14th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Natural Microbial Defences & Immunity Conference Speakers
Recommended Sessions
- Advances in Antimicrobial Vaccines
- Bacteria and pollution control
- Bacterial food infections
- Bacterial gastroenteritis
- Bacterial Oral/ Mouth Infections
- Bacterial Pathogenesis
- Bacterial pulmonary infections (Pneumonia)
- Bacteriophage
- Emerging Infectious Diseases
- Entrepreneurs Investment Meet
- Industrial and Applied Bacteriology
- Market Analysis and Manufactures
- Microbial genomics
- Multi Pathogen Infections
- Natural Microbial Defences & Immunity
- Surgical site infections (SSIs)
Related Journals
Are you interested in
- Advances in Chronic Kidney Disease (CKD) Management: - GLOBAL INFECTIONS 2027 (France)
- Antimicrobial Resistance & Stewardship - Tuberculosis 2027 (France)
- Antimicrobial Resistance (AMR) - Infectious Meet 2027 (France)
- Artificial Intelligence and Machine Learning in Nephrology: - GLOBAL INFECTIONS 2027 (France)
- Asthma & Airway Diseases - Tuberculosis 2027 (France)
- Bacterial & Fungal Infectious Diseases - Infectious Diseases_2026 (France)
- Bacterial and Parasitic Diseases - Infectious Meet 2027 (France)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Cardio-Renal Syndromes: - GLOBAL INFECTIONS 2027 (France)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Chronic Obstructive Pulmonary Disease - Tuberculosis 2027 (France)
- Clinical and Case Reports - INFECTIOUS DISEASES-2027 (France)
- Clinical Infectious Diseases and Case Management - Infectious Meet 2027 (France)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Clinical Research and Public Awareness - Infectious Diseases_2026 (France)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2027 (France)
- Coronavirus(nCOV) - Infectious Diseases_2026 (France)
- Critical Care & Respiratory Emergencies - Tuberculosis 2027 (France)
- Diagnosis, Management and Treatment of Infections: - GLOBAL INFECTIONS 2027 (France)
- Diagnostics and Laboratory Technologies - Infectious Meet 2027 (France)
- Digital Health and Disease Surveillance - Infectious Meet 2027 (France)
- Disinfection and Sterilization - Infection Control 2026 (UK)
- Drug-Resistant & Multidrug-Resistant Tuberculosis - Tuberculosis 2027 (France)
- Ebola and Zika Viral Infections - Infectious Diseases_2026 (France)
- Emerging & Infectious Disease: - GLOBAL INFECTIONS 2027 (France)
- Emerging and Re-emerging Infectious Diseases - Infectious Meet 2027 (France)
- Emerging Infectious Diseases - Infection Control 2026 (UK)
- Epidemiology - INFECTIOUS DISEASES-2027 (France)
- Epidemiology and Public Health - Infectious Meet 2027 (France)
- Foodborne and Waterborne Diseases - Infectious Meet 2027 (France)
- Fungal & Parasitic Infectious Disease: - GLOBAL INFECTIONS 2027 (France)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Future Trends and Innovations in Infectious Diseases - Infectious Meet 2027 (France)
- Genetic and Molecular Insights in Nephrology: - GLOBAL INFECTIONS 2027 (France)
- Global Health and Policy - Infectious Meet 2027 (France)
- Global Trends in Emerging Infectious Diseases - Infectious Diseases_2026 (France)
- Health Disparities in Nephrology and Infectious Diseases: - GLOBAL INFECTIONS 2027 (France)
- Hepatitis Prevention - Infection Control 2026 (UK)
- HIV Prevention, Treatment and Cure - Infection Control 2026 (UK)
- HIV/AIDS - Infectious Diseases_2026 (France)
- HIV/AIDS and Sexually Transmitted Infections - Infectious Meet 2027 (France)
- Immunology and Host-Pathogen Interactions - Infectious Meet 2027 (France)
- Immunology of Infections - Infectious Diseases_2026 (France)
- Impact of COVID-19 on Kidney Health: - GLOBAL INFECTIONS 2027 (France)
- Infection Control Bacteriology - Infection Control 2026 (UK)
- Infection Control Business - Infection Control 2026 (UK)
- Infection Control in Dental - Infection Control 2026 (UK)
- Infection Control in Dental - Infection Control 2026 (UK)
- Infection Control in Nephrology Units: - GLOBAL INFECTIONS 2027 (France)
- Infection Control Precautions - Infection Control 2026 (UK)
- Infection Control Treatment & Diagnosis - Infection Control 2026 (UK)
- Infection Prevention and Control (IPC) - Infectious Meet 2027 (France)
- Infection Treatment and Control - Infection Control 2026 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2027 (France)
- Infectious Disease Pathology - Infection Control 2026 (UK)
- Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2026 (France)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2027 (France)
- Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2026 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2027 (France)
- Influenza and Diagnostic Approaches - Infection Control 2026 (UK)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Interstitial Lung Diseases & Pulmonary Fibrosis - Tuberculosis 2027 (France)
- Interventional Pulmonology & Bronchoscopy - Tuberculosis 2027 (France)
- Latent Tuberculosis Infection & Preventive Therapy - Tuberculosis 2027 (France)
- Malaria and Hepatitis - Infectious Diseases_2026 (France)
- Mechanical Ventilation & Respiratory Support - Tuberculosis 2027 (France)
- Molecular Bacteriology Infection: - GLOBAL INFECTIONS 2027 (France)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2026 (France)
- Nosocomial Infections - Infectious Diseases_2026 (France)
- Nosocomial Infections & Control - Infection Control 2026 (UK)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2027 (France)
- Nursing Infection Control - Infection Control 2026 (UK)
- One Health Approach - Infectious Meet 2027 (France)
- Pandemic Preparedness and Response - Infectious Meet 2027 (France)
- Parasitic Diseases - Infectious Diseases_2026 (France)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Pediatric Infectious Disease: - GLOBAL INFECTIONS 2027 (France)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2026 (France)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Pneumonia & Lower Respiratory Tract Infections - Tuberculosis 2027 (France)
- Practical Guidelines - Infection Control 2026 (UK)
- Practices & Awareness - Infection Control 2026 (UK)
- Pulmonary Hypertension & Vascular Lung Diseases - Tuberculosis 2027 (France)
- Pulmonary Tuberculosis & Extrapulmonary TB - Tuberculosis 2027 (France)
- Pulmonology & Clinical Respiratory Medicine - Tuberculosis 2027 (France)
- Rare Diseases in Cancer and Aging - Infectious Diseases_2026 (France)
- Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2026 (France)
- Renal Replacement Therapy: Innovations and Challenges: - GLOBAL INFECTIONS 2027 (France)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2027 (France)
- Respiratory & Pulmonary Infections - Tuberculosis 2027 (France)
- Respiratory Diseases - Infectious Diseases_2026 (France)
- Risk Factors & Prevention - Infection Control 2026 (UK)
- Risk Factors & Prevention - Infection Control 2026 (UK)
- Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2026 (France)
- Surgical Site Infections - Infectious Diseases_2026 (France)
- TB Prevention, Screening & Infection Control - Tuberculosis 2027 (France)
- Telemedicine in Nephrology and Infectious Diseases: - GLOBAL INFECTIONS 2027 (France)
- Treatment for Tuberculosis - Infection Control 2026 (UK)
- Tropical and Neglected Diseases - Infectious Meet 2027 (France)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Tuberculosis - Infectious Diseases_2026 (France)
- Tuberculosis and Respiratory Infections - Infectious Meet 2027 (France)
- Tuberculosis Diagnostics & Molecular Technologies - Tuberculosis 2027 (France)
- Tuberculosis: Diagnosis, Treatment & Clinical Management - Tuberculosis 2027 (France)
- Vaccination for Infectious Diseases: - GLOBAL INFECTIONS 2027 (France)
- Vaccine Development and Immunization Strategies - Infectious Meet 2027 (France)
- Vaccine Research & Development - Infection Control 2026 (UK)
- Vaccines and Vaccination - Infectious Diseases_2026 (France)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2027 (France)
- Veterinary Diseases - INFECTIOUS DISEASES-2027 (France)
- Veterinary Infection Control - Infection Control 2026 (UK)
- Veterinary Infectious Disease: - GLOBAL INFECTIONS 2027 (France)
- Viral & Bacterial Infectious Disease: - GLOBAL INFECTIONS 2027 (France)
- Viral Infectious Diseases - Infectious Diseases_2026 (France)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Virology and Viral Infections - Infectious Meet 2027 (France)
- Zoonotic and Vector-Borne Diseases - Infectious Meet 2027 (France)
